Pharmaceutical Technology
FEBRUARY 24, 2023
Amivantamab overview Amivantamab-vmjw (Rybrevant) is a low-fucose human immunoglobulin G1-based bispecific antibody developed using recombinant DNA technology. It is based on DuoBody technology platform. It is formulated as solution and concentrate for solution for intravenous infusion.
Pharma Packaging Solutions
JUNE 30, 2023
Biopharmaceuticals, also called biologics, are drug products that are manufactured using biological sources. Semi-Synthesized: Though the term “biologic” is accurate for the extracted materials listed above, it is more often used to describe therapeutics that are produced with recombinant DNA technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Packaging Solutions
SEPTEMBER 22, 2023
Biologics are drug products that are manufactured using materials from living sources. There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. Let’s talk about it. What are Biologics?
Cloudbyz
MARCH 6, 2024
This shift signifies not just a change in the way drugs are manufactured and administered, but also a fundamental transformation in the approach to treating diseases at their root cause. In this blog post, we delve into the rise of biologics and explore how they are reshaping the pharmaceutical industry and improving patient outcomes.
Roots Analysis
JANUARY 21, 2024
Conventional conjugation technologies used for the development of ADCs exploited the superficial lysine residues that were inherent to the native antibody structure, or the inter-chain cysteine residues, for drug-linker attachment.
Expert insights. Personalized for you.
100 
Let's personalize your content